Scheen AJ, Paquot N
Understanding how medications interact is important because it can impact your health and how well the drugs work
This study specifically focused on adverse events classified under the Eye Disorders System Organ Class (SOC code: 10015919) in cases where HCQ or CQ was used for the treatment of systemic lupus erythematosus, with the aim of detecting potential ocular toxicity induced by these drugs
Tabata et al., 1999) are illustrative for the pertinence of the poorly resolved problem, illustrative for the diversity of the carriers (i.e., hyaluronate gel carrier (Wang and Aspengberg, 1996), alginate/heparinsacharose microspheres and films (Yu et al., 1998), cellulose gel (Thorn and Aspenberg, 1993), defective form of Pseudomonas exotoxin (Siegall et al., 1994), fibrin adhesive carrier (Walter et al., 1996), biodegredable hydrogen gelatin (Tabata et al., 1999), natural coral, and collagen (Damien et al., 1993))